# MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

> **NCT00174798** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 118 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** SSR240600C
- **DRUG:** Placebo
- **DRUG:** Tolterodine

## Key facts

- **NCT ID:** NCT00174798
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-05
- **Final completion:** 2006-05
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174798, "MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00174798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*